---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-017590"
form_type: "8-K"
ticker: "IMDX"
cik: "0001642380"
company_name: "Insight Molecular Diagnostics Inc."
filed_at: "2025-07-02T23:59:59+00:00"
generated_at: "2026-05-18T09:38:34.515734+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve all four proposals at Insight Molecular Diagnostics 2025 annual meeting

## Summary
- 73.46% quorum achieved; all four director nominees (Riggs, Arno, Last, Silverman) elected.
- Ratified CBIZ CPAs P.C. as independent auditor for FY 2025 with 20,986,994 votes for.
- Non-binding say-on-pay proposal approved with 18,063,639 votes for.
- Amendment to 2018 Equity Incentive Plan approved; shares authorized increased by 1,500,000 to 3,800,000.

## SEC filing metadata
- accession: 0001641172-25-017590
- form_type: 8-K
- ticker: IMDX
- cik: 0001642380
- company_name: Insight Molecular Diagnostics Inc.
- filed_at: 2025-07-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642380/000164117225017590/0001641172-25-017590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642380/000164117225017590/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-017590
- JSON: https://secwatch.observer/filing/0001641172-25-017590.json
- Plain text: https://secwatch.observer/filing/0001641172-25-017590.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.